Rockwell Medical Inc. (RMTI) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Rockwell Medical Inc. (RMTI)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

2.00

-0.01 (-0.50%)

At close: Jan 14, 2025, 3:59 PM

2.07

3.76%

After-hours Jan 14, 2025, 05:33 PM EST

undefined% (undefined)

Bid	1.99
Market Cap	64.48M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.04
PE Ratio (ttm)	-49.87
Forward PE	n/a
Analyst	Buy

Ask	2.07
Volume	241,702
Avg. Volume (20D)	726,406
Open	2.06
Previous Close	2.01
Day's Range	1.98 - 2.06
52-Week Range	1.16 - 5.15
Beta	undefined

About RMTI

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stor...

[Show more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

IPO Date Jan 27, 1998

Employees 237

Stock Exchange NASDAQ

Ticker Symbol RMTI

Website https://www.rockwellmed.com

Analyst Forecast

According to 2 analyst ratings, the average rating for RMTI stock is "Buy." The 12-month stock price forecast is $6, which is an increase of 200.75% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Rockwell Medical Inc. is scheduled to release its earnings on Mar 20, 2025, before market opens.
Analysts project revenue of $25.16M, reflecting a 13.88% YoY growth and earnings per share of 0.01, making a -50.00% decrease YoY.

Why Price Moved

4 weeks ago · Source

+10.45%

Rockwell Medical shares are trading higher after t... Unlock content with Pro Subscription

2 months ago · Source

-39.14%

Rockwell Medical shares are trading lower. The company reported Q3 financial results.

News

4 weeks ago · businesswire.com

Rockwell Medical Enters into a Multi-Year Product Purchase Agreement with the World's Leading Provider of Dialysis Products and Services

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical is the leading supplier of liquid bicarbonate in the United States.

1 month ago · businesswire.com

Rockwell Medical Promotes Jesse Neri to Chief Financial Officer

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Jesse Neri has been instrumental in strengthening Rockwell Medical's financial infrastructure and developing a stronger financial organi...

1 month ago · businesswire.com

Rockwell Medical Partners with HydroCare to Distribute and Install its Dry Acid Concentrate Mix System

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's DAMX45 dry acid concentrate mix system is 510(k) approved to be used exclusively with the Company's dry acid concentr...

1 month ago · businesswire.com

Rockwell Medical Expands Distribution in the Philippines

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will be the exclusive supplier of all dry hemodialysis concentrates products to Nephro Group.

2 months ago · seekingalpha.com

Rockwell Medical's Dip Gives A Speculative Opportunity

Despite a 39% stock drop yesterday, Rockwell Medical's strong Q3 results and upcoming catalyst provide a solid buying opportunity for risk-takers. The stock's dip was due to reduced orders from its la...

2 months ago · seekingalpha.com

Rockwell Medical, Inc. (RMTI) Q3 2024 Earnings Call Transcript

Rockwell Medical, Inc. (NASDAQ:RMTI ) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Heather Hunter - Senior Vice President & Chief Corporate Affairs Officer Mark S...

2 months ago · zacks.com

Rockwell Medical (RMTI) Surpasses Q3 Earnings and Revenue Estimates

Rockwell Medical (RMTI) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to loss of $0.07 per share a year ago.

2 months ago · businesswire.com

Rockwell Medical Reports Third Quarter 2024 Earnings, Generates Profitability on a Cash Flow and Adjusted EBITDA Basis for the Second Consecutive Quarter

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced financial and operational results for the three and nine months ended September 30, 2024.

2 months ago · businesswire.com

Rockwell Medical Announces Date Change for Third Quarter 2024 Earnings Conference Call and Webcast

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--UPDATED Q3'24 EARNINGS DATE: Rockwell Medical will release its third quarter 2024 financial and operational results on November 12, 2024...

2 months ago · zacks.com

RMTI Stock Rises 138% in Q3: What Should You Do Ahead of Earnings?

Rockwell Medical expects its Q3 results to gain from a high rate of customer conversions toward it compared with its primary competitor.

2 months ago · zacks.com

Rockwell Medical on Expansion Spree: Should You Buy the Stock Now?

This year can be regarded as a momentous period for RMTI's business because this is the first time in its history that it has achieved steady revenue growth.

2 months ago · zacks.com

Rockwell Medical (RMTI) Upgraded to Buy: Here's Why

Rockwell Medical (RMTI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

3 months ago · businesswire.com

Rockwell Medical to Release Third Quarter 2024 Results on Monday, November 11, 2024

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its financial and operational results for the third quarter ended September 30, 2024 on Monday, November 1...